Anterior Uveitis (AU): Clinical Trials

1 trial for Anterior Uveitis (AU), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Anterior Uveitis (AU): new trials by email Literature Review of Anterior Uveitis (AU) trials Research Report on Anterior Uveitis (AU)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
Certolizumab Pegol - Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU)
Phase 4CompletedUCB Biopharma SRL892016-12-212026-06-23

Narrower conditions

Axial Spondyloarthritis (1)  ·  Uveitis, Anterior (1)

Broader conditions

Ankylosis (1)  ·  Arthritis (1)  ·  Bone Diseases (1)  ·  Eye Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Panuveitis (1)  ·  Spinal Diseases (1)  ·  Spondylarthritis (1)  ·  Spondylarthropathies (1)  ·  Spondylitis (1)  ·  Uveal Diseases (1)  ·  Uveitis (1)

Interventions

Certolizumab Pegol (1)

Sponsors

UCB Biopharma SRL (1)

Countries

Czechia (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)

Results publications

PMID 33854572, PMID 41919656

NIH funding

2016 (1)